|
HSPA1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.255800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.203000E-01 |
| Normal-vs-Stage2 |
1.279550E-01 |
| Normal-vs-Stage3 |
8.332200E-01 |
| Normal-vs-Stage4 |
3.626200E-01 |
| Stage1-vs-Stage2 |
1.684650E-01 |
| Stage1-vs-Stage3 |
7.482600E-01 |
| Stage1-vs-Stage4 |
3.349600E-01 |
| Stage2-vs-Stage3 |
3.046400E-01 |
| Stage2-vs-Stage4 |
6.720600E-01 |
| Stage3-vs-Stage4 |
4.356000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.316000E-01 |
| Normal-vs-AfricanAmerican |
2.267800E-02 |
| Normal-vs-Asian |
1.763350E-01 |
| Caucasian-vs-AfricanAmerican |
1.917850E-03 |
| Caucasian-vs-Asian |
4.990000E-01 |
| AfricanAmerican-vs-Asian |
1.195690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.669600E-01 |
| Normal-vs-Female |
2.922300E-02 |
| Male-vs-Female |
2.580400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.595800E-02 |
| Normal-vs-Extreme_Weight |
2.166400E-01 |
| Normal-vs-Obese |
2.192600E-01 |
| Normal-vs-Extreme_Obese |
1.740400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.099800E-03 |
| Normal_Weight-vs-Obese |
2.745800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.333000E-01 |
| Extreme_Weight-vs-Obese |
2.547900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.989750E-02 |
| Obese-vs-Extreme_Obese |
6.829400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.115400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.661000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.227800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.869920E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.882000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.149000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.243200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.442750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.930290E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.320980E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.370400E-01 |
| Normal-VS-Type2 PRCC |
3.457600E-02 |
| Normal-VS-KIRP CIMP |
3.263200E-01 |
| Normal-VS-Unclassified PRCC |
1.080770E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.438440E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.420000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.545710E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.524000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.911800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.128600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.174400E-01 |
| Normal-vs-N1 |
8.035000E-01 |
| Normal-vs-N2 |
3.124800E-01 |
| N0-vs-N1 |
6.836000E-01 |
| N0-vs-N2 |
6.658800E-01 |
| N1-vs-N2 |
5.094800E-01 |
|
|
